Successive supply of a reimbursed medicinal product under the drug programme for the treatment of patients with primary IgA nephropathy (ICD-10: N02.8) B.171 for the needs of the Provincial Integrated Hospital in Kielce

Summary

The contract concerns successive deliveries of a reimbursed medicinal product for the drug programme treating patients with primary IgA nephropathy (ICD-10: N02.8) B.171 for the Provincial Integrated Hospital in Kielce. The package is not divided into lots. The bidder must offer a medicinal product authorised for marketing and compliant with the current Ministry of Health reimbursement notice. Delivery must be made within 3 working days of a written order sent by email. The price must not exceed the financing limit set in the reimbursement notice. Award criteria are price (80%) and invoice payment term (20%), with up to 60 days for payment.